Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017101
University of California Sys Office/Pres, Oakland, CA, United States
Search grants from University of California Sys Office/Pres
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Systematic Functional Characterization of RNA Editing in Endometrial Cancer
Identification of microRNA variants associated with acute lymphoblastic leukemia
Molecular and cellular mechanisms of heterotopic ossification
Mechanism of Energy Coupling by DNA Topoisomerase II
Reactivity of Molecularly Defined Mycobacterial Antigens
Recently added grants:
HIV, HCV, Hippo, and Liver Disease Progression
Serial Killers to Mosquitos: The Spatial Targeting of Larval habitats in rural Uganda using geographic Profiling
Bayesian modeling of mood-driven decision biases for predicting clinical outcome
Cognitive Training as a Novel Neuroscience-based Treatment for PTSD
Disrupted Neural Connectivity in Empathy Deficits in Schizophrenia
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017101-002
Application #
6688650
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of California Sys Office/Pres
Department
Type
DUNS #
003985512
City
Oakland
State
CA
Country
United States
Zip Code
94607
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
Comments
Be the first to comment on this grant